Isradipine improves platelet function in hypertensives View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1992-01

AUTHORS

H. Sinzinger, I. Virgolini, F. Rauscha, P. Fitscha, J. O'Grady

ABSTRACT

The effect of treatment for eight weeks with isradipine 1.25 mg twice daily for 4 weeks and thereafter 2.5 mg twice daily for 4 weeks on ex vivo platelet function was investigated in 10 male hypertensive patients, aged 51 (6.1) y. Systolic and diastolic blood pressure, platelet aggregation in response to ADP, serum thromboxane B2 and beta-thromboglobulin levels were significantly decreased at rest before exercise ergometry, during exercise and at rest after exercise. The platelet count, platelet sensitivity and the plasma levels of 6-oxo-prostaglandin F1 alpha were not affected by isradipine. It is concluded that a compound that lowers blood pressure and inhibits platelet activation may be of clinical benefit in the routine treatment of hypertension. More... »

PAGES

43-46

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00314918

DOI

http://dx.doi.org/10.1007/bf00314918

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1005960838

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/1531796


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Analysis of Variance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antihypertensive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Platelets", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Pressure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Calcium Channel Blockers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dihydropyridines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Epoprostenol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypertension", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Isradipine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Platelet Aggregation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prostaglandin D2", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Wilhelm Auerswald-Atherosclerosis Research Group (ASF), Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sinzinger", 
        "givenName": "H.", 
        "id": "sg:person.0774566513.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774566513.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Wilhelm Auerswald-Atherosclerosis Research Group (ASF), Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Virgolini", 
        "givenName": "I.", 
        "id": "sg:person.0764224033.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0764224033.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Wilhelm Auerswald-Atherosclerosis Research Group (ASF), Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rauscha", 
        "givenName": "F.", 
        "id": "sg:person.01022360525.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022360525.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "2nd Department of Internal Medicine, Polyclinic, Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fitscha", 
        "givenName": "P.", 
        "id": "sg:person.052462543.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.052462543.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Vienna", 
          "id": "https://www.grid.ac/institutes/grid.10420.37", 
          "name": [
            "Department of Pharmacology, University of Vienna, Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "O'Grady", 
        "givenName": "J.", 
        "id": "sg:person.0635300045.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635300045.15"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/0049-3848(89)90089-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005391147"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0021-9150(88)90087-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023192128"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0021-9150(79)90202-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026392925"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.res.42.4.562", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042677578"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-8703(83)90285-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049207021"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.res.43.1.115", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050987766"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0262-1746(86)90196-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052160031"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079966655", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1992-01", 
    "datePublishedReg": "1992-01-01", 
    "description": "The effect of treatment for eight weeks with isradipine 1.25 mg twice daily for 4 weeks and thereafter 2.5 mg twice daily for 4 weeks on ex vivo platelet function was investigated in 10 male hypertensive patients, aged 51 (6.1) y. Systolic and diastolic blood pressure, platelet aggregation in response to ADP, serum thromboxane B2 and beta-thromboglobulin levels were significantly decreased at rest before exercise ergometry, during exercise and at rest after exercise. The platelet count, platelet sensitivity and the plasma levels of 6-oxo-prostaglandin F1 alpha were not affected by isradipine. It is concluded that a compound that lowers blood pressure and inhibits platelet activation may be of clinical benefit in the routine treatment of hypertension.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/bf00314918", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1054337", 
        "issn": [
          "0031-6970", 
          "1432-1041"
        ], 
        "name": "European Journal of Clinical Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "42"
      }
    ], 
    "name": "Isradipine improves platelet function in hypertensives", 
    "pagination": "43-46", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "1c64ea9fd4e4f0e40ecefaefd5fae5d98aa6a422bfc6fc2b3d6b8a0da360d163"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "1531796"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "1256165"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00314918"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1005960838"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00314918", 
      "https://app.dimensions.ai/details/publication/pub.1005960838"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:54", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000371_0000000371/records_130811_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/BF00314918"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00314918'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00314918'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00314918'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00314918'


 

This table displays all metadata directly associated to this object as RDF triples.

188 TRIPLES      21 PREDICATES      52 URIs      36 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00314918 schema:about N20f74def90154eeea1e902db94e515ff
2 N5016d0819257477d9e7d46d2389a0aec
3 N55c6902088b1457dab1396ffe0f41545
4 N64ffdcce4be34adca6fa22770b7daa41
5 N8151c9d346b44d8dbdf2972e058277b1
6 N824438a41e704748a929551a04c82d3f
7 Nbb2292d0e06c4d079f362730dde1d502
8 Nbe8e3b519fa842759fc89c462d68a9ac
9 Nc21fb6a74d1d4caf8800583b7c0945d7
10 Nc982c29754954a4fae1780c04aa300e0
11 Ncf52336f29f2429993ef4cb4577370d0
12 Nda244177fe6e44a0a4dda7d6aa7efbad
13 Ne323aa427ae24d4c9df7dd4052c3f797
14 Nefee2fadfcd740f69e0563bf697a95cb
15 Nf085fa04a8074950b186bae62ea935e9
16 anzsrc-for:11
17 anzsrc-for:1102
18 schema:author N49da6d7e879a4e75a0122a68de759a9e
19 schema:citation https://app.dimensions.ai/details/publication/pub.1079966655
20 https://doi.org/10.1016/0002-8703(83)90285-5
21 https://doi.org/10.1016/0021-9150(79)90202-8
22 https://doi.org/10.1016/0021-9150(88)90087-1
23 https://doi.org/10.1016/0049-3848(89)90089-3
24 https://doi.org/10.1016/0262-1746(86)90196-4
25 https://doi.org/10.1161/01.res.42.4.562
26 https://doi.org/10.1161/01.res.43.1.115
27 schema:datePublished 1992-01
28 schema:datePublishedReg 1992-01-01
29 schema:description The effect of treatment for eight weeks with isradipine 1.25 mg twice daily for 4 weeks and thereafter 2.5 mg twice daily for 4 weeks on ex vivo platelet function was investigated in 10 male hypertensive patients, aged 51 (6.1) y. Systolic and diastolic blood pressure, platelet aggregation in response to ADP, serum thromboxane B2 and beta-thromboglobulin levels were significantly decreased at rest before exercise ergometry, during exercise and at rest after exercise. The platelet count, platelet sensitivity and the plasma levels of 6-oxo-prostaglandin F1 alpha were not affected by isradipine. It is concluded that a compound that lowers blood pressure and inhibits platelet activation may be of clinical benefit in the routine treatment of hypertension.
30 schema:genre research_article
31 schema:inLanguage en
32 schema:isAccessibleForFree false
33 schema:isPartOf N23e2f00e94fe472dac46ef5ea94c5b22
34 N3178c7bd029447b3b68d3da8618f22a2
35 sg:journal.1054337
36 schema:name Isradipine improves platelet function in hypertensives
37 schema:pagination 43-46
38 schema:productId N39f81dc3f40341dfa8ab020ec2ecf2d0
39 N60e97886efd043168f9db2ab4d989abc
40 N7087562350ef48e3bf58b6debf01a928
41 N8ab1218c3e5c44c1811f699ea97b5aee
42 Nfee494a3d5dd485b96f47b364055103c
43 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005960838
44 https://doi.org/10.1007/bf00314918
45 schema:sdDatePublished 2019-04-11T13:54
46 schema:sdLicense https://scigraph.springernature.com/explorer/license/
47 schema:sdPublisher N8f23ca9bcc304c94b01093de3ebad874
48 schema:url http://link.springer.com/10.1007/BF00314918
49 sgo:license sg:explorer/license/
50 sgo:sdDataset articles
51 rdf:type schema:ScholarlyArticle
52 N1b78652cf9724ed2a54fc0f6e069680a schema:name 2nd Department of Internal Medicine, Polyclinic, Vienna, Austria
53 rdf:type schema:Organization
54 N20f74def90154eeea1e902db94e515ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
55 schema:name Heart Rate
56 rdf:type schema:DefinedTerm
57 N23e2f00e94fe472dac46ef5ea94c5b22 schema:issueNumber 1
58 rdf:type schema:PublicationIssue
59 N3178c7bd029447b3b68d3da8618f22a2 schema:volumeNumber 42
60 rdf:type schema:PublicationVolume
61 N39f81dc3f40341dfa8ab020ec2ecf2d0 schema:name pubmed_id
62 schema:value 1531796
63 rdf:type schema:PropertyValue
64 N3a179f8afe3743ad9d59dcb0c0e77bd3 schema:name Wilhelm Auerswald-Atherosclerosis Research Group (ASF), Vienna, Austria
65 rdf:type schema:Organization
66 N49da6d7e879a4e75a0122a68de759a9e rdf:first sg:person.0774566513.24
67 rdf:rest N96efb227c6394c2baa5059d55764c921
68 N5016d0819257477d9e7d46d2389a0aec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Prostaglandin D2
70 rdf:type schema:DefinedTerm
71 N55c6902088b1457dab1396ffe0f41545 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Male
73 rdf:type schema:DefinedTerm
74 N60e97886efd043168f9db2ab4d989abc schema:name readcube_id
75 schema:value 1c64ea9fd4e4f0e40ecefaefd5fae5d98aa6a422bfc6fc2b3d6b8a0da360d163
76 rdf:type schema:PropertyValue
77 N64ffdcce4be34adca6fa22770b7daa41 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Dihydropyridines
79 rdf:type schema:DefinedTerm
80 N7087562350ef48e3bf58b6debf01a928 schema:name doi
81 schema:value 10.1007/bf00314918
82 rdf:type schema:PropertyValue
83 N7e118434059145b789017f2e829dd918 schema:name Wilhelm Auerswald-Atherosclerosis Research Group (ASF), Vienna, Austria
84 rdf:type schema:Organization
85 N8151c9d346b44d8dbdf2972e058277b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Isradipine
87 rdf:type schema:DefinedTerm
88 N824438a41e704748a929551a04c82d3f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Analysis of Variance
90 rdf:type schema:DefinedTerm
91 N8ab1218c3e5c44c1811f699ea97b5aee schema:name nlm_unique_id
92 schema:value 1256165
93 rdf:type schema:PropertyValue
94 N8f23ca9bcc304c94b01093de3ebad874 schema:name Springer Nature - SN SciGraph project
95 rdf:type schema:Organization
96 N96efb227c6394c2baa5059d55764c921 rdf:first sg:person.0764224033.26
97 rdf:rest Ncc11d2483c7f455fae4c1c68fe328305
98 N9c3f969da75e4a2ab1bf554dad1ce18e schema:name Wilhelm Auerswald-Atherosclerosis Research Group (ASF), Vienna, Austria
99 rdf:type schema:Organization
100 Nbb2292d0e06c4d079f362730dde1d502 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Epoprostenol
102 rdf:type schema:DefinedTerm
103 Nbe0ec2e9bd2c4717b3290b920e2eed57 rdf:first sg:person.0635300045.15
104 rdf:rest rdf:nil
105 Nbe8e3b519fa842759fc89c462d68a9ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Blood Platelets
107 rdf:type schema:DefinedTerm
108 Nc21fb6a74d1d4caf8800583b7c0945d7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Platelet Aggregation
110 rdf:type schema:DefinedTerm
111 Nc284c589e0e64783ab94e9a03ff00a22 rdf:first sg:person.052462543.13
112 rdf:rest Nbe0ec2e9bd2c4717b3290b920e2eed57
113 Nc982c29754954a4fae1780c04aa300e0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Hypertension
115 rdf:type schema:DefinedTerm
116 Ncc11d2483c7f455fae4c1c68fe328305 rdf:first sg:person.01022360525.28
117 rdf:rest Nc284c589e0e64783ab94e9a03ff00a22
118 Ncf52336f29f2429993ef4cb4577370d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Humans
120 rdf:type schema:DefinedTerm
121 Nda244177fe6e44a0a4dda7d6aa7efbad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Antihypertensive Agents
123 rdf:type schema:DefinedTerm
124 Ne323aa427ae24d4c9df7dd4052c3f797 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Calcium Channel Blockers
126 rdf:type schema:DefinedTerm
127 Nefee2fadfcd740f69e0563bf697a95cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Middle Aged
129 rdf:type schema:DefinedTerm
130 Nf085fa04a8074950b186bae62ea935e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Blood Pressure
132 rdf:type schema:DefinedTerm
133 Nfee494a3d5dd485b96f47b364055103c schema:name dimensions_id
134 schema:value pub.1005960838
135 rdf:type schema:PropertyValue
136 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
137 schema:name Medical and Health Sciences
138 rdf:type schema:DefinedTerm
139 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
140 schema:name Cardiorespiratory Medicine and Haematology
141 rdf:type schema:DefinedTerm
142 sg:journal.1054337 schema:issn 0031-6970
143 1432-1041
144 schema:name European Journal of Clinical Pharmacology
145 rdf:type schema:Periodical
146 sg:person.01022360525.28 schema:affiliation N3a179f8afe3743ad9d59dcb0c0e77bd3
147 schema:familyName Rauscha
148 schema:givenName F.
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022360525.28
150 rdf:type schema:Person
151 sg:person.052462543.13 schema:affiliation N1b78652cf9724ed2a54fc0f6e069680a
152 schema:familyName Fitscha
153 schema:givenName P.
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.052462543.13
155 rdf:type schema:Person
156 sg:person.0635300045.15 schema:affiliation https://www.grid.ac/institutes/grid.10420.37
157 schema:familyName O'Grady
158 schema:givenName J.
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635300045.15
160 rdf:type schema:Person
161 sg:person.0764224033.26 schema:affiliation N9c3f969da75e4a2ab1bf554dad1ce18e
162 schema:familyName Virgolini
163 schema:givenName I.
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0764224033.26
165 rdf:type schema:Person
166 sg:person.0774566513.24 schema:affiliation N7e118434059145b789017f2e829dd918
167 schema:familyName Sinzinger
168 schema:givenName H.
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774566513.24
170 rdf:type schema:Person
171 https://app.dimensions.ai/details/publication/pub.1079966655 schema:CreativeWork
172 https://doi.org/10.1016/0002-8703(83)90285-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049207021
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1016/0021-9150(79)90202-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026392925
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1016/0021-9150(88)90087-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023192128
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1016/0049-3848(89)90089-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005391147
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1016/0262-1746(86)90196-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052160031
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1161/01.res.42.4.562 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042677578
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1161/01.res.43.1.115 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050987766
185 rdf:type schema:CreativeWork
186 https://www.grid.ac/institutes/grid.10420.37 schema:alternateName University of Vienna
187 schema:name Department of Pharmacology, University of Vienna, Vienna, Austria
188 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...